LiDCO*: Forecast revisions (CORP) | EKF Diagnostics: Tender wins (BUY) | Alumasc: Better-than-expected FY results (BUY)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
03 Sep 2015 -
Author:
David Buxton | Cavendish Research - Pages:
LiDCO*: Forecast revisions (CORP) | EKF Diagnostics: Tender wins (BUY) | Alumasc: Better-than-expected FY results (BUY)